Company's Bio (Pitch Deck): Established in 2013, Tress Capital is a leading institutional-grade cannabis investment management firm embedded at the core of the cannabis industry, supported by a world-class infrastructure. With a unique industry network, unparalleled deal-flow pipeline, and experienced team with in-house niche expertise, Tress is the go-to for sophisticated investors seeking competence. Tress originates, guides, and manages investment for HNW, SFO, and institutional clients in both fund and bespoke SMA vehicles. Tress works closely with its companies and sector as an active value-add investor. The Tress portfolio includes industry leaders such as SC Labs, Headset, Baker Technologies (TILT), Cannabis Now, Grownetics, North Bud and Infusion Biosciences.
C-Suite Bio's (Pitch Deck): David Hess is President and Co-Founder of Tress Capital, LLC. Founded in 2013, Tress Capital is a strategic venture capital firm embedded at the core of the global cannabis sector. Tress originates and manages investment for high-net-worth, family office, and institutional investors. Tress has a track record of successful industry investment and works closely with its companies and the industry providing active value-add support. The Tress portfolio includes industry leaders such as SC Labs, Headset, Baker Technologies, Cannabis Now, Grownetics, North Bud and Infusion Biosciences. A two time cancer survivor, David was introduced to the vast benefits of medical cannabis while undergoing cancer treatments in 2001 and again in 2003. David has since dedicated himself to furthering research, awareness, and business opportunities in the expanding cannabis industry.
Market Data 
Markets 
AI
